scholarly journals Association between semiologic, autonomic, and electrographic seizure characteristics in children with generalized tonic-clonic seizures

2021 ◽  
Vol 122 ◽  
pp. 108228
Author(s):  
Rima El Atrache ◽  
Eleonora Tamilia ◽  
Marta Amengual-Gual ◽  
Fatemeh Mohammadpour Touserkani ◽  
Yonghua Yang ◽  
...  
1991 ◽  
Vol 49 (3) ◽  
pp. 333-337 ◽  
Author(s):  
A. Cukiert ◽  
G. Gronich ◽  
R. Marino Jr.

A 32 years old woman who had postural limbic and primarily generalized tonic-clonic seizures since the age of 11 presented to us with a CT image strongly suggestive of a mesial meningeoma near the right cingulum. Her ictal EEG pattern was characterized by regular 1.5-2.0 Hz sharp and slow wave complexes. A right craniotomy was performed under general anesthesia and intraoperative electroencephalographic and electrocorticographic recordings were obtained by means of scalp steel electrodes and modified cerebellar stimulation electrodes, respectively. These recordings demonstrated that surface spikes were often independent from the electrocorticographically recorded ones. Before tumor excision, electrical stimulation of the peritumoral mesial cortex resulted in an increase in the epileptic activity. The stimulation of the cavity left after tumor excision led to a prolonged electrographic seizure and neurophysiological procedures were stopped. Post-operatively, the patient has remained seizure free for 6 months and her EEG was normal. The pre-, intra- and post-operative findings in this case suggest that the gliotic peritumoral mesial cortex was at least involved in the epileptogenic process.


2019 ◽  
Vol 19 (9) ◽  
pp. 699-703
Author(s):  
Shihao Zhou ◽  
Qiong Zhan ◽  
Xiaomei Wu

Background: This study aimed to explore the clinical effect of levetiracetam in the treatment of children with epilepsy. Methods: 136 children with epilepsy were selected from January 2017 to December 2017. According to the random number table method, they were divided into the experimental group and the conventional group, with 68 cases in each group. The conventional group was treated with valproate, while the experimental group was treated with levetiracetam. The effective rate, the cognitive function and the frequency of clonic seizures in the two groups were compared. Results: There was no significant difference in the total effective rate between the two groups (P>0.05). There was no significant difference in attention, executive ability, abstract and orientation scores between the two groups before treatment (P>0.05). After treatment, the focus of attention (106.54±6.56), executive ability (105.76±6.77), abstract and directional score (106.65±6.57) were significantly higher than that of the conventional group. The difference in the two groups was statistically significant (P<0.05). After 3 months of treatment, the frequency of myoclonic seizures (9.22±0.95) and the frequency of tonic-clonic seizures (11.68±1.36) were found to be significantly lower than those of the conventional group, and the difference between the two groups was statistically significant (P<0.05). Conclusion: Levetiracetam is effective in the treatment of children with epilepsy. It can effectively improve the cognitive function of the patients, reduce the frequency of myoclonic seizures and tonic-clonic seizures, and has a high promotion value.


2020 ◽  
Vol 13 (3) ◽  
pp. e233584
Author(s):  
Christian Danstrup ◽  
Maria Andersen

A 60-year-old man was found unconscious at work, without any signs of trauma. At the site, he presented with tonic-clonic seizures, central facial palsy and eye deviation. A CT scan of the cerebrum did not find bleeding or thrombosis, but contrast enhancement at the superior sagittal sinus and pathological cervical lymph nodes. The MRI demonstrated multiple intracerebral metastases, while a supplementary fluoro-deoxy-glucose positron emission tomography scan revealed metastatic lesions above and below the diaphragm, without signs of a primary tumour. An ear, nose and throat examination found a small supraglottic tumour and cervical lymph node metastases. Following a multidisciplinary team discussion, biopsies from the duodenal mucosa and an inguinal lymph node were performed, showing squamous cell carcinoma with its origin in the head and neck. The patient was diagnosed with a T1N2cM1 supraglottic laryngeal cancer, receiving palliative whole brain radiation therapy but died 11 weeks after the debut of symptoms.


Author(s):  
Mitchell A. Frankel ◽  
Mark J. Lehmkuhle ◽  
Meagan Watson ◽  
Kirsten Fetrow ◽  
Lauren Frey ◽  
...  

Author(s):  
Yonghua Yang ◽  
Rani Sarkis ◽  
Rima El Atrache ◽  
Tobias Loddenkemper ◽  
Christian Meisel

Author(s):  
Ciria C Hernandez ◽  
XiaoJuan Tian ◽  
Ningning Hu ◽  
Wangzhen Shen ◽  
Mackenzie A Catron ◽  
...  

Abstract Dravet syndrome is a rare, catastrophic epileptic encephalopathy that begins in the first year of life, usually with febrile or afebrile hemiclonic or generalized tonic-clonic seizures followed by status epilepticus. De novo variants in genes that mediate synaptic transmission such as SCN1A and PCDH19 are often associated with Dravet syndrome. Recently, GABAA receptor subunit genes (GABRs) encoding α1 (GABRA1), β3 (GABRB3) and γ2 (GABRG2), but not β2 (GABRB2) or β1 (GABRB1), subunits are frequently associated with Dravet syndrome or Dravet syndrome-like phenotype. We performed next generation sequencing on 870 patients with Dravet syndrome and identified nine variants in three different GABRs. Interestingly, the variants were all in genes encoding the most common GABAA receptor, the α1β2γ2 receptor. Mutations in GABRA1 (c.644T&gt;C, p.L215P; c.640C&gt;T, p.R214C; c.859G&gt;A; V287I; c.641G&gt;A, p.R214H) and GABRG2 (c.269C&gt;G, p.T90R; c.1025C&gt;T, p.P342L) presented as de novo cases, while in GABRB2 two variants were de novo (c.992T&gt;C, p.F331S; c.542A&gt;T, p.Y181F) and one was autosomal dominant and inherited from the maternal side (c.990_992del, p.330_331del). We characterized the effects of these GABR variants on GABAA receptor biogenesis and channel function. We found that defects in receptor gating were the common deficiency of GABRA1 and GABRB2 Dravet syndrome variants, while mainly trafficking defects were found with the GABRG2 (c.269C&gt;G, p.T90R) variant. It seems that variants in α1 and β2 subunits are less tolerated than in γ2 subunits, since variant α1 and β2 subunits express well but were functionally deficient. This suggests that all of these GABR variants are all targeting GABR genes that encode the assembled α1β2γ2 receptor, and regardless of which of the three subunits are mutated, variants in genes coding for α1, β2 and γ2 receptor subunits make them candidate causative genes in the pathogenesis of Dravet syndrome.


PLoS ONE ◽  
2020 ◽  
Vol 15 (4) ◽  
pp. e0230510
Author(s):  
F. Deeba ◽  
P. Sanz-Leon ◽  
P. A. Robinson

2016 ◽  
Vol 369 ◽  
pp. 330-332
Author(s):  
Ali A. Asadi-Pooya ◽  
Amin H. Rabiei ◽  
Edward J. Gracely ◽  
Michael R. Sperling

NeuroImage ◽  
2010 ◽  
Vol 50 (3) ◽  
pp. 902-909 ◽  
Author(s):  
Matthew N. DeSalvo ◽  
Ulrich Schridde ◽  
Asht M. Mishra ◽  
Joshua E. Motelow ◽  
Michael J. Purcaro ◽  
...  
Keyword(s):  

2016 ◽  
Vol 68 (4) ◽  
pp. 680-685 ◽  
Author(s):  
Magdalena Chrościńska-Krawczyk ◽  
Małgorzata Jargiełło-Baszak ◽  
Marta Andres-Mach ◽  
Jarogniew J. Łuszczki ◽  
Stanisław J. Czuczwar

Sign in / Sign up

Export Citation Format

Share Document